Nicolet Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$376K Buy
3,932
+966
+33% +$94.7K 0.03% 280
2025
Q3
$284K Buy
2,966
+45
+2% +$4.66K 0.02% 328
2025
Q2
$308K Buy
2,921
+655
+29% +$66.3K 0.03% 299
2025
Q1
$210K Sell
2,266
-89
-4% -$8.96K 0.02% 352
2024
Q4
$223K Buy
+2,355
New +$207K 0.02% 350
2024
Q3
Sell
-3,777
Closed -$291K 371
2024
Q2
$291K Buy
3,777
+148
+4% +$10.8K 0.03% 282
2024
Q1
$249K Buy
3,629
+165
+5% +$10.6K 0.03% 303
2023
Q4
$201K Buy
+3,464
New +$185K 0.02% 306
2023
Q3
Sell
-4,827
Closed -$255K 318
2023
Q2
$255K Buy
4,827
+109
+2% +$5.69K 0.03% 255
2023
Q1
$236K Buy
+4,718
New +$222K 0.03% 253

Other funds holding BSX

Nicolet Advisory Services's BSX Position: Q4 2025 in Review

Nicolet Advisory Services increased its Boston Scientific (BSX) stake by 33% in Q4 2025, buying an estimated $94.7K and bringing the position to 3,932 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #280.

Nicolet Advisory Services first reported a position in BSX in Q1 2023 and has held it in 10 quarters since. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Nicolet Advisory Services held 3,932 shares of Boston Scientific worth $376K as of Q4 2025.
  • Nicolet Advisory Services bought 966 Boston Scientific shares in Q4 2025, an estimated $94.7K.
  • Boston Scientific made up 0.03% of Nicolet Advisory Services's portfolio in Q4 2025, its #280 holding.
  • Nicolet Advisory Services first reported a position in Boston Scientific in Q1 2023 and has held it in 10 quarters since.
  • 1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.